Robert Nelsen

Robert Nelsen

Fortuna: 2 M $ al 31/05/2026

62 años
Health Technology
Commercial Services
Finance

Perfil

Robert Nelsen is a co-founder and a Managing Director of ARCH Venture Partners.
Some of his notable early-stage investments include Illumina (ILMN), Alnylam Pharmaceuticals (ALNY), June Therapeutics (JUNO – acquired by Celgene), Beam Therapeutics (BEAM), Karuna Therapeutics (KRTX), Altos Labs, EQRx (EQRX), National Resilience, Prime Medicine, Lyell Immunopharma (LYEL), Array BioPharma (ARRY – acquired by Pfizer), Hua Medicine (2552:HK), Vir Biotechnology (VIR), Insitro, Agios Pharmaceuticals (AGIO), Sage Therapeutics (SAGE), GRAIL (acquired by Illumina), Gossamer Bio (GOSS), Ikaria (acquired by Mallinckrodt), Kythera Biopharmaceuticals (KYTH – acquired by Allergan), Receptos (RCPT – acquired by Celgene), Aviron (AVIR – acquired by MedImmune), Denali Therapeutics (DNLI), Syros Pharmaceuticals (SYRS), Sana Biotechnology (SANA), Verve Therapeutics (VERV), Brii Biosciences (2137:HK), Bluebird Bio (BLUE), R2 Technology (acquired by Hologic), Caliper Life Sciences (CALP – acquired by PerkinElmer), Trubion Pharmaceuticals (TRBN – acquired by Emergent Biosolutions), Adolor (ADLR – acquired by Cubist Pharmaceuticals), deCODE Genetics (DCGN – acquired by Amgen), Editas (EDIT), 10x Genomics, Semma Therapeutics (acquired by Vertex Pharmaceuticals), Element, and IDUN Pharmaceuticals (acquired by Pfizer).
Mr. Nelsen is a director of VIR, SANA, LYEL, National Resilience, Insitro, Prime Medicine, Nutcracker Therapeutics, Neumora Therapeutics, Brii Biosciences, and serves as Chairman of Hua Medicine, among others.
He previously served as a Trustee of the Fred Hutchinson Cancer Research Institute, the Institute of Systems Biology, and was a director of the National Venture Capital association.
Mr. Nelsen holds an M.B.A. from the University of Chicago and a B.S.
from the University of Puget Sound with majors in Economics and Biology.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
31/03/2025 60.615 ( 0,06 % ) 2 M $ 31/05/2026
05/06/2026 100.142 ( 0,06 % ) 355 504 $ 31/05/2026
31/12/2024 150.000 ( 0,01 % ) 50 336 $ 31/05/2026
04/06/2026 13.853 ( 0,01 % ) 45 715 $ 31/05/2026

Cargos activos de Robert Nelsen

EmpresasCargoInicio
HUA MEDICINE (SHANGHAI) LTD. Presidente 23/04/2010
PRIME MEDICINE, INC. Director/Miembro de la Junta 01/09/2020
SANA BIOTECHNOLOGY, INC. Fundador 13/07/2018
Fundador 28/06/2010
Director/Miembro de la Junta 01/01/2022
Presidente -
Hua Medicine Technology (Hong Kong) Ltd.
Director/Miembro de la Junta 01/08/2010
Director/Miembro de la Junta -
Director/Miembro de la Junta -
░░░░ ░░░░░░░ ░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░

Antiguos cargos conocidos de Robert Nelsen.

EmpresasCargoFin
░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Robert Nelsen.

Formación de Robert Nelsen.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

63

Relaciones de 1er grado

80

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas80

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Finance

Finance

Process Industries

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Energy Minerals

Health Technology

Health Technology

Health Technology

Producer Manufacturing

Health Technology

Miscellaneous

Consumer Services

Technology Services

Consumer Services

Finance

Health Technology

Commercial Services

Health Technology

Commercial Services

Commercial Services

Commercial Services

Finance

Commercial Services

Health Technology

Finance

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Technology Services

Health Technology

Hua Medicine Technology (Hong Kong) Ltd.

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Health Technology

Health Services

Health Technology

Health Technology

Finance

Commercial Services

Brii Biosciences (Beijing) Co. Ltd.

Brii Biosciences (Hong Kong) Co. Ltd.

Health Technology

Finance

Health Technology

Health Technology

Technology Services

Health Technology

Technology Services

-40%: ¡Descubre las mejores inversiones del futuro con las herramientas para suscriptores!
d
:
:
APROVECHAR LA PROMOCIÓN